Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral FMT in Advanced HCC After Progression on ICI-TKI Therapy
NCT06563947Phase 2Recruiting
- Start
- Sep 2024
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in hepatocellular carcinoma (HCC). Started Sep 2024; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT06563947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06563947.